Skip to main content

Borden Lacy Archives

Versatile C. difficile blocker

Jan. 26, 2018—New research reveals a unique mechanism of C. difficile toxin neutralization by a monoclonal antibody, suggesting new therapeutic approaches.

Read more


15 faculty members elected as AAAS fellows

Nov. 20, 2017—Fifteen Vanderbilt faculty members conducting a range of biomedical and clinical research have been elected fellows of the American Association for the Advancement of Science. Six of the 15 have received funding through the university’s Trans-Institutional Programs initiative, which facilitates research and teaching collaborations across disciplines and are a core pillar of the university’s Academic Strategic Plan.

Read more


Inaugural Stanley Cohen Lecture is March 4

Feb. 23, 2016—Ray Stevens, the Provost Professor of Chemistry and Molecular Biology at the University of Southern California, presents the inaugural Stanley Cohen Lecture Friday, March 4.

Read more


Crystal structure reveals secrets of virulent bacterium

Jan. 14, 2016—Researchers at Vanderbilt University Medical Center have obtained the crystal structure of a toxin from the bacterium Clostridium difficile (“C. diff”) — the leading cause of hospital-acquired diarrhea in the United States.

Read more


Study identifies C. diff toxin receptor, suggests new treatment approaches

Jun. 4, 2015—Vanderbilt University investigators have identified a cellular receptor for a toxin from Clostridium difficile (“C. diff”) — the leading cause of hospital-acquired diarrhea in the United States.

Read more


VUMC Academic Enterprise Faculty Award winners announced

May. 26, 2015—The 2015 Vanderbilt University Medical Center Academic Enterprise Faculty Awards, which were presented during the May 19 Spring Faculty meeting, included awards for Excellence in Teaching and Outstanding Contributions to Research.

Read more


Cutting-edge research to be showcased in May

May. 1, 2014—Potentially “game-changing” research at Vanderbilt University on infectious diseases, population health and health policy will be showcased during two interactive presentations May 15 and May 22. A segment of the Flexner Discovery Lecture Series, the new “Vanderbilt Cutting-edge Discovery” discussions are highlights of recent presentations to the Vanderbilt Biomedical Science Advisory Board, a group of...

Read more


Vanderbilt awarded $16.5 million agreement to determine how toxic agents affect human cells

Mar. 3, 2014—Vanderbilt University has been awarded a Cooperative Agreement with the Defense Advanced Research Projects Agency and the Army Research Office that is worth up to $16.5 million over five years.

Read more


Defusing ‘C. diff’ infection

Nov. 8, 2013—Clostridium difficile (“C. diff”) infection is a leading cause of hospital-associated diarrhea, and the frequency and severity of infections are on the rise. D. Borden Lacy, Ph.D., associate professor of Pathology, Microbiology and Immunology, and colleagues recently demonstrated that the C. difficile toxin, TcdB, induces rapid cell death of human colon cell lines and pig colonic...

Read more


Lacy’s crystallographic research achievements recognized

Sep. 19, 2013—D. Borden Lacy, Ph.D., associate professor of Pathology, Microbiology and Immunology, and Biochemistry, will receive the 2014 Margaret Etter Award from the American Crystallographic Association (ACA) for outstanding achievement and exceptional potential in crystallographic research demonstrated by a scientist at an early stage of their independent career.

Read more


Upcoming Events

MORE EVENTS »